DFTX

20.68

0.39% 0.08

Dopo l'orario di chiusura: 20.78 0.10 +0.48%

Definium Therapeutics Inc (DFTX)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

Precedente Chiudi:

$20.60

Aprire:

$20.15

Volume 24 ore:

1.95M

Relative Volume:

1.42

Capitalizzazione di mercato:

$2.06B

Reddito:

Utile/perdita netta:

$-183.79M

Rapporto P/E:

-9.9947

EPS:

-2.0691

Flusso di cassa netto:

$-131.84M

1 W Prestazione:

+9.19%

1M Prestazione:

+20.37%

6M Prestazione:

+0.00%

1 anno Prestazione:

+0.00%

Intervallo 1D:

$19.95

$21.09

Intervallo di 1 settimana:

$17.13

$21.09

Portata 52W:

$14.62

$21.09

Definium Therapeutics Inc Stock (DFTX) Company Profile

Nome

Definium Therapeutics Inc

Settore

Healthcare (1118)

Industria

Biotechnology (624)

Telefono

212-220-6633

Indirizzo

ONE WORLD TRADE CENTER, NEW YORK

Dipendente

106

Cinguettio

Prossima data di guadagno

Ultimi documenti SEC

DFTX's Discussions on Twitter

Compare DFTX vs VRTX, REGN, ARGX, ALNY, INSM

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
DFTX Definium Therapeutics Inc	20.68	2.06B	0	-183.79M	-131.84M	-2.0691
VRTX Vertex Pharmaceuticals Inc	438.71	111.45B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	761.85	80.54B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	746.42	46.32B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	318.85	42.29B	3.71B	313.75M	465.38M	2.2571
INSM Insmed Inc	162.43	35.01B	606.42M	-1.28B	-997.58M	-6.403

Definium Therapeutics Inc Stock (DFTX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-02-24	Iniziato	Wolfe Research	Outperform
2026-01-30	Iniziato	Jefferies	Buy
2025-10-13	Iniziato	Needham	Buy
2025-08-04	Ripresa	Oppenheimer	Outperform
2025-01-28	Iniziato	Evercore ISI	Outperform
2024-12-20	Iniziato	Chardan Capital Markets	Buy
2024-10-14	Ripresa	Leerink Partners	Outperform
2024-07-24	Iniziato	ROTH MKM	Buy
2024-05-29	Iniziato	Robert W. Baird	Outperform
2024-04-15	Iniziato	Leerink Partners	Outperform
2023-12-05	Iniziato	Canaccord Genuity	Buy
2022-12-09	Ripresa	ROTH Capital	Buy
2022-11-16	Iniziato	RBC Capital Mkts	Outperform
2022-08-26	Iniziato	Oppenheimer	Outperform
2022-08-10	Iniziato	Cantor Fitzgerald	Overweight
2022-05-04	Iniziato	ROTH Capital	Buy
2021-06-28	Iniziato	Maxim Group	Buy

Mostra tutto

Definium Therapeutics Inc Borsa (DFTX) Ultime notizie

04:08 AM

Price performance - Yahoo Finance Singapore

04:08 AM

Apr 04, 2026

Do Definium Therapeutics’ (DFTX) New Hires Hint At A Deeper Bet On Anxiety Treatments? - Sahm

Apr 04, 2026

Apr 03, 2026

Can Definium Therapeutics (DFTX) Turn GAD Prevalence And DT120 Breakthrough Status Into Durable Advantage? - finance.yahoo.com

Apr 03, 2026

Total non-current liabilities of Definium Therapeutics, Inc. – NASDAQ:DFTX - TradingView

Apr 03, 2026

Apr 02, 2026

Definium Therapeutics stock hits 52-week high at 19.78 USD By Investing.com - Investing.com Canada

Apr 02, 2026

Apr 01, 2026

Definium Therapeutics (NASDAQ:DFTX) Sets New 52-Week HighHere's Why - MarketBeat

Apr 01, 2026

Definium Therapeutics stock hits 52-week high at 19.78 USD - Investing.com

Apr 01, 2026

Mar 31, 2026

New Definium Therapeutics Study Published in the Journal of Mood and Anxiety Disorders Reveals Increasing Prevalence and Burden of Generalized Anxiety Disorder in the United States - BioSpace

Mar 31, 2026

Definium Therapeutics (DFTX) Study Highlights Rising GAD Rates i - GuruFocus

Mar 31, 2026

Anxiety disorder prevalence rises to 6.6% in U.S., study finds By Investing.com - Investing.com Australia

Mar 31, 2026

Anxiety disorder prevalence rises to 6.6% in U.S., study finds - Investing.com

Mar 31, 2026